Detect fusion genes with SeqOne!
RNAseq analysis is now possible using the SeqOne Platform so that you can include the detection of expressed SNVs, Indels and fusion genes in your analysis.
We are proud to introduce our easy-to-use and intuitive fusion gene interface that visually indicates:
- Fusion gene details such as the identified partner,
- Specific exon and coordinates of the breakpoint.
- The number of reads containing the fusion gene: to increase the confidence in results.
A link to the Cosmic database helps you to easily interpret whether the fusion is pathogenic and the interface also reports the protein’s domain, providing you with important information to assist you in choosing the best therapy for each patient.
Similar readings
-
News Platform features Press release Science9 February 2023
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
Montpellier, February 9th, 2023: SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving [...]
-
News Platform features
27 September 2021
SeqOne unlocks the power of Illumina’s TruSightTM Oncology 500
With the addition of the TSO500 pan-cancer NGS assay for genomic profiling of tumour samples, SeqOne now provides oncologists with the most comprehensive genomic data [...]
-
Platform features Science
14 May 2020
Mobile element insertion (MEI) detection for NGS based clinical diagnostics
A growing number of scientific articles describe the pathogenic role of MEI’s, bringing a renewed focus on their importance in clinical diagnosis. Although NGS makes [...]
Comments